GE Healthcare, which has its North American headquarters in Wauwatosa, today announced it has received Food and Drug Administration (FDA)clearance for its Discovery IGS 740, a rail-free mobile angiography system.
“Our goal is to pioneer a solution designed to free interventional radiologists from traditional constraints,” said Chantal Le Chat, general manager of GE Healthcare Premium Angiography. “With the enhanced mobility of the Discovery IGS 740, clinicians have full freedom to operate, and we believe this can revolutionize the field of interventional imaging.”
According to the company, “This new imaging system puts interventional radiologists at the center of their procedures. The rail-free design allows healthcare professionals ample access to the patient while freeing clinical teams from the constraints of fixed ceiling-mounted system rails. Its wide bore C-Arm and dedicated arm-imaging positions create ease in imaging the anatomy of interest, and full patient access from the left or right. A rotating laser continuously scans the room so the system knows where it is at all times.
“By eliminating the ceiling rails, installation is simplified for flexibility in designing the room and positioning ceiling-mounted ancillaries (monitors, radshields, lights) where healthcare professionals need them.”